NPHC
Nutra Pharma Corp
Going-concern doubt
— flagged May 29, 2026
Substantial doubt about the company's ability to continue as a going concern.
“There is substantial doubt regarding our ability to continue as a going concern which is contingent upon our ability to secure additional financing, increase ownership equity and attain profitable operations.”View the 10-Q filed May 29, 2026
Company with tickers: NPHC
CIK
1119643
Shares Outstanding
7,159,727,214
Website
https://www.nutrapharma.com
Investor Relations
https://www.nutrapharma.com/investor-relations
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $27,246 | USD | 2026-03-31 | 10-Q | 2026-05-29 |
| Cost of Revenue | — | ||||
| Gross Profit | $18,975 | USD | 2026-03-31 | 10-Q | 2026-05-29 |
| Operating Expenses | $398,224 | USD | 2026-03-31 | 10-Q | 2026-05-29 |
| Research & Development | — | ||||
| Operating Income | $-379,249 | USD | 2026-03-31 | 10-Q | 2026-05-29 |
| Net Income | $-459,675 | USD | 2026-03-31 | 10-Q | 2026-05-29 |
| EPS (Basic) | $0.00 | USD/shares | 2026-03-31 | 10-Q | 2026-05-29 |
| EPS (Diluted) | $0.00 | USD/shares | 2026-03-31 | 10-Q | 2026-05-29 |